Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-20714-2
Abstract: BRD4 (“Bromodomain-containing protein 4”), a recognized gene regulator, is an attractive target for therapeutic development, particularly for the management of neuroblastoma. An integrated pharmacoinformatic strategy for the development of new BRD4 inhibitors is examined in…
read more here.
Keywords:
computational discovery;
neuroblastoma therapy;
brd4 inhibitors;
inhibitors neuroblastoma ... See more keywords